检验医学 ›› 2025, Vol. 40 ›› Issue (5): 493-498.DOI: 10.3969/j.issn.1673-8640.2025.05.014

• 论著 • 上一篇    下一篇

乳酸/白蛋白比值在AECOPD患者通气治疗近期和远期预后评估中的价值

徐丹丹   

  1. 德清县人民医院呼吸与危重症医学科,浙江 湖州 313200
  • 收稿日期:2024-03-20 修回日期:2024-09-02 出版日期:2025-05-30 发布日期:2025-06-04
  • 作者简介:徐丹丹,女,1986 年生,学士,主治医师,主要从事呼吸内科相关疾病的诊疗工作。

Role of lactic acid/albumin ratio in short-term and long-term prognosis evaluation of ventilation therapy in AECOPD patients

XU Dandan   

  1. Department of Respiratory and Critical Care Medicine,Deqing County People's Hospital,Huzhou 313200,Zhejiang,China
  • Received:2024-03-20 Revised:2024-09-02 Online:2025-05-30 Published:2025-06-04

摘要:

目的 探讨血乳酸(Lac)/白蛋白(Alb)比值在慢性阻塞性肺疾病急性加重期(AECOPD)患者通气治疗预后评估中的价值。方法 选取2021年3月—2023年3月德清县人民医院AECOPD患者235例,收集所有患者入院时的基线资料,并检测Lac、Alb水平,计算Lac/Alb比值。根据通气治疗期间和随访1年的预后情况将患者分别分为近期预后良好组、近期预后不良组和远期预后良好组、远期预后不良组。采用多因素Logistic回归分析评价AECOPD患者近期和远期预后的影响因素。采用受试者工作特征(ROC)曲线评价各项指标判断AECOPD患者通气治疗近期和远期预后不良的效能。结果 235例AECOPD患者通气治疗期间有60例(25.53%)预后不良,出院后随访1年,有68例(28.94%)预后不良。近期预后不良组年龄≥60岁所占比例、机械通气所占比例、急性生理与慢性健康评分Ⅱ(APACHEⅡ)、Lac、Lac/Alb比值均高于近期预后良好组(P<0.05),Alb低于近期预后良好组(P<0.05);其他项目2个组之间差异均无统计学意义(P>0.05)。APACHEⅡ评分、Lac、Alb、Lac/Alb比值单项检测和APACHEⅡ评分、Lac/Alb比值联合检测判断AECOPD患者近期预后不良的曲线下面积(AUC)分别为0.824、0.732、0.742、0.827、0.910。年龄、APACHEⅡ评分、Lac、Alb和Lac/Alb比值是AECOPD患者近期预后不良的危险因素(P<0.05)。远期预后不良组年龄≥60岁所占比例、合并冠心病所占比例、APACHEⅡ评分、Lac、Lac/Alb比值均高于远期预后良好组(P<0.05),Alb低于远期预后良好组(P<0.001);其他项目2个组之间差异均无统计学意义(P>0.05)。APACHEⅡ评分、Lac、Alb、Lac/Alb比值和APACHEⅡ评分、Lac/Alb比值联合检测判断AECOPD患者远期预后不良的AUC分别为0.835、0.745、0.776、0.844、0.926。APACHEⅡ评分、合并冠心病、Alb、Lac/Alb比值是AECOPD患者远期预后不良的危险因素(P<0.05)。结论 Lac/Alb比值与AECOPD患者通气治疗近期预后和远期预后均有关。Lac/Alb比值联合APACHEⅡ评分对AECOPD患者通气治疗近期预后和远期预后均有较高的预测价值。

关键词: 乳酸/白蛋白比值, 慢性阻塞性肺疾病, 急性加重, 通气治疗, 预后评估

Abstract:

Objective To investigate the role of blood lactic acid (Lac)/albumin (Alb) ratio in the prognostic evaluation of ventilation therapy in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods A total of 235 patients with AECOPD were enrolled from Deqing County People's Hospital from March 2021 to March 2023. Baseline data were collected at admission,and Lac and Alb levels were determined to calculate Lac/Alb ratio. Based on the prognosis during ventilation therapy and a one-year follow-up,the patients were classified into short-term good prognosis group,short-term poor prognosis group,long-term good prognosis group and long-term poor prognosis group. Multivariate Logistic regression was used to analyze the factors affecting the short-term and long-term prognosis. The efficacy of ventilation therapy in AECOPD patients with poor short-term and long-term prognosis was evaluated by various indicators. Results During ventilation therapy,60 out of 235 AECOPD patients (25.53%) had poor prognosis. After a one-year follow-up,68 out of 235 AECOPD patients (28.94%) had poor prognosis. The proportion of patients aged≥60 years,mechanical ventilation,acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ)score,Lac levels and Lac/Alb ratio in short-term poor prognosis group were all higher than those in short-term good prognosis group (P<0.05),while Alb was lower(P<0.05). There was no statistical significance in the other data between the 2 groups (P>0.05). The areas under curves (AUC) of APACHE Ⅱ score,Lac,Alb,Lac/Alb ratio and APACHE Ⅱ score combined with Lac/Alb ratio for predicting short-term poor prognosis in AECOPD patients were 0.824,0.732,0.742,0.827 and 0.910,respectively. Age,APACHE Ⅱ score,Lac,Alb and Lac/Alb ratio were the influencing factors for the short-term prognosis of AECOPD patients (P<0.05). The proportion of patients aged≥60 years,the proportion of patients with concomitant coronary heart disease,APACHE Ⅱ score,Lac and Lac/Alb ratio in long-term poor prognosis group were all higher than those in long-term good prognosis group (P<0.05),while Alb was lower(P<0.001). There was no statistical significance in the other parameters between the 2 groups (P>0.05). The AUC of APACHE Ⅱ score,Lac,Alb,Lac/Alb ratio and APACHE Ⅱ score combined with Lac/Alb ratio for predicting long-term poor prognosis were 0.835,0.745,0.776,0.844 and 0.926,respectively. APACHE Ⅱ score,coronary heart disease,Alb and Lac/Alb ratio were the influencing factors for the long-term prognosis of AECOPD patients (P<0.05). Conclusions The Lac/Alb ratio is associated with both short-term and long-term prognosis of ventilation therapy in AECOPD patients. The Lac/Alb ratio combined with APACHE Ⅱ score,Lac and Alb have high predictive value for both short-term and long-term prognosis of ventilation therapy in AECOPD patients.

Key words: Lactic acid/albumin ratio, Chronic obstructive pulmonary disease, Acute exacerbation, Ventilation therapy, Prognostic assessment

中图分类号: